Apolipoprotein E polymorphism has no independent effect on plasma levels of lipoprotein(a)

被引:12
|
作者
Ritter, MM [1 ]
Gewitsch, J [1 ]
Richter, WO [1 ]
Geiss, HC [1 ]
Wildner, MW [1 ]
Schwandt, P [1 ]
机构
[1] UNIV MUNICH,INST MED INFORMAT BIOMETR & EPIDEMIOL,MUNICH,GERMANY
关键词
lipoprotein(a); apolipoprotein E; genetic polymorphism; triglyceride concentration; LDL-cholesterol concentration;
D O I
10.1016/S0021-9150(97)06105-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Previous studies show conflicting results concerning an influence of apolipoprotein E (ape E) phenotype on lipoprotein(a) (Lp(a)) plasma levels. We speculated that it is not the apo E phenotype itself but rather its effect on plasma lipid concentrations that might influence Lp(a) levels. In 1562 subjects concentrations of triglycerides, LDL-cholesterol and Lp(a) were measured by standard laboratory methods. Apo(a) and apo E isoforms were determined by sodium dodecyl sulfate gel electrophoresis and isoelectric focusing, respectively, followed by immunoblotting. An univariate analysis revealed a significant influence of apo(a) isoforms, apo E phenotype, triglycerides and LDL-cholesterol on Lp(a) plasma levels (ANOVA: P < 0.001, P < 0.02, P < 0.001 and P < 0.001, respectively). In a multivariate analysis, however, the influence of the apo E phenotype was no longer significant (P > 0.10), whereas apo(a) isoforms, LDL-cholesterol quintiles and triglyceride quintiles explained 29.2, 2.8 and 1.0% of the variation of the Lp(a) levels (for all three variables: P < 0.001). We conclude that apo E polymorphism does not exert an independent effect on Lp(a) concentrations. Any influence is mediated through the effect of apo E polymorphism on plasma lipids. (C) 1997 Elsevier Science Ireland Ltd.
引用
收藏
页码:243 / 248
页数:6
相关论文
共 50 条
  • [41] Effect of apolipoprotein E polymorphism on serum uric acid levels in healthy subjects
    Liberopoulos, EN
    Miltiadous, GA
    Athyros, VG
    Ganotakis, M
    Cariolou, M
    Bairaktari, E
    Elisaf, MS
    JOURNAL OF INVESTIGATIVE MEDICINE, 2005, 53 (03) : 116 - 122
  • [42] INFLUENCE OF APOLIPOPROTEIN-E POLYMORPHISM ON PLASMA-LIPOPROTEIN RESPONSE TO A HIGH-CARBOHYDRATE DIET
    LAFLEUR, D
    DAVIGNON, J
    LUSSIERCACAN, S
    CLINICAL AND INVESTIGATIVE MEDICINE, 1985, 8 (03): : A46 - A46
  • [43] FREQUENCY AND EFFECT OF HUMAN APOLIPOPROTEIN-A-IV POLYMORPHISM ON LIPID AND LIPOPROTEIN LEVELS IN AN ICELANDIC POPULATION
    MENZEL, HJ
    SIGURDSSON, G
    BOERWINKLE, E
    SCHRANGLWILL, S
    DIEPLINGER, H
    UTERMANN, G
    HUMAN GENETICS, 1990, 84 (04) : 344 - 346
  • [44] GENETIC-POLYMORPHISM OF APOLIPOPROTEIN-B, APOLIPOPROTEIN-E, AND LIPOPROTEIN-LIPASE, AND SERUM-LIPOPROTEIN LEVELS IN SURVIVORS OF MYOCARDIAL-INFARCTION
    KAUPPINENMAKELIN, R
    JARVINEN, P
    KONTULA, K
    AALTOSETALA, K
    EHNHOLM, C
    TENKANEN, H
    TASKINEN, MR
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 1993, 3 (03) : 118 - 127
  • [45] Identification of a Functional Apolipoprotein E Promoter Polymorphism Regulating Plasma Apolipoprotein E Concentration
    Mannila, Maria Nastase
    Mahdessian, Hovsep
    Franco-Cereceda, Anders
    Eggertsen, Gosta
    de Faire, Ulf
    Syvanen, Ann-Christine
    Eriksson, Per
    Hamsten, Anders
    van 't Hooft, Ferdinand M.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2013, 33 (05) : 1063 - U490
  • [46] Apolipoprotein E polymorphism has no cross sectional association with C-reactive protein levels in women
    Lowndes, Joshua
    Zoeller, Robert F.
    Moyna, Niall M.
    Gordon, Paul M.
    Visich, Paul S.
    Pescatell, Linda S.
    Miles, Mary P.
    Seip, Richard L.
    Thompson, Paul D.
    Angelopoulos, Theodore J.
    FASEB JOURNAL, 2007, 21 (06): : A868 - A868
  • [47] No independent influence of the apolipoprotein E polymorphism on the carotid artery atherosclerosis
    Kauma, H
    Paivansalo, M
    Savolainen, MJ
    Rantala, AO
    Lilja, M
    Kervinen, K
    Kesaniemi, AY
    CIRCULATION, 1997, 96 (08) : 3673 - 3673
  • [48] The relationship between apolipoprotein e polymorphism, lipoprotein (a) and fatty liver disease
    Yang, MH
    Son, HJ
    Sung, JD
    Choi, YH
    Koh, KC
    Yoo, BC
    Paik, SW
    HEPATO-GASTROENTEROLOGY, 2005, 52 (66) : 1832 - 1835
  • [49] LIPOPROTEIN AND APOLIPOPROTEIN PROFILE IN MEN WITH ISCHEMIC STROKE - ROLE OF LIPOPROTEIN(A), TRIGLYCERIDE-RICH LIPOPROTEINS, AND APOLIPOPROTEIN E POLYMORPHISM
    PEDROBOTET, J
    SENTI, M
    NOGUES, X
    RUBIESPRAT, J
    ROQUER, J
    DOLHABERRIAGUE, L
    OLIVE, J
    STROKE, 1992, 23 (11) : 1556 - 1562
  • [50] Reduction of plasma glycosphingolipid levels has no impact on atherosclerosis in apolipoprotein E-null mice
    Glaros, Elias N.
    Kim, Woojin S.
    Rye, Kerry-Anne
    Shayman, James A.
    Garner, Brett
    JOURNAL OF LIPID RESEARCH, 2008, 49 (08) : 1677 - 1681